Jason C. Gallagher, PharmD

Clinical Professor
Temple University
Philadelphia, PA, United States

Dr. Jason Gallagher is Clinical Professor at Temple University School of Pharmacy and Clinical Pharmacy Specialist in Infectious Diseases at Temple University Hospital. He also is the Director of the PGY2 Residency in Infectious Diseases Pharmacy at Temple and Editor-in-Chief of Contagion. He is a past President of the Society of Infectious Diseases Pharmacists and currently serves on the IDSA guideline panel for the treatment and management of COVID-19.

Disclosure(s): No financial relationships to disclose

Presentation(s):

• 124 - Therapy for Carbapenem-Resistant Organisms in the Real World

  Friday, October 18, 2024
  10:30 AM – 11:45 AM US PT

• 311 - Defining the magnitude of desirability of outcome ranking (DOOR) differences in effectiveness of Ceftazidime-Avibactam (CZA) versus Ceftolozane-Tazobactam (C/T) for multidrug-resistant (MDR) Pseudomonas aeruginosa infections in the United States (CACTUS)

  Friday, October 18, 2024
  10:42 AM – 10:54 AM US PT

• 312 - Impact of Patient Subgroups on the Efficacy of Ceftazidime-Avibactam (CZA) versus Ceftolozane-Tazobactam (C/T) for Multidrug-resistant (MDR) Pseudomonas aeruginosa infections in the United States (CACTUS)

  Friday, October 18, 2024
  10:54 AM – 11:06 AM US PT

• 586 - Let's Have a Chat: How Well Does an Artificial Intelligence Chatbot Answer Clinical Infectious Diseases Questions?

  Saturday, October 19, 2024
  2:45 PM – 2:57 PM US PT